U.S. markets closed

Zealand Pharma A/S (ZEAL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
31.95+0.06 (+0.19%)
At close: 9:30AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close31.89
Open31.50
Bid31.63 x 1300
Ask31.90 x 1100
Day's Range31.82 - 31.82
52 Week Range24.97 - 44.42
Volume41
Avg. Volume33,953
Market Cap1.386B
Beta (5Y Monthly)0.85
PE Ratio (TTM)N/A
EPS (TTM)-4.41
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est37.84
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Zealand Pharma A/S
    XNCR: What does Argus have to say about XNCR?XENCOR INC has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more